Literature DB >> 17166586

Bacterial proteins and CpG-rich extrachromosomal DNA in potential cancer therapy.

Magdy Mahfouz1, Wataru Hashimoto, Tapas K Das Gupta, Ananda M Chakrabarty.   

Abstract

Bacterial proteins such as azurin and Laz have recently been shown to enter preferentially to cancer cells and kill them by multiple mechanisms. Historically, bacterial DNA, particularly the unmethylated CpG dinucleotides, have been shown to trigger activation of specific Toll-like receptors (TLRs) in immune cells, leading to various cytokine and chemokine production that allows cancer cell death and their regression. However, the enhanced release of specific protein or extrachromosomal DNA by bacteria in response to exposure to cancer cells has not been previously demonstrated. In this review, we discuss how an opportunistic, extracellular pathogenic bacterium, Pseudomonas aeruginosa, senses the presence of cancer cells and releases a specific protein or extrachromosomal DNA with antitumor activity for inhibition of cancer cell growth.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17166586     DOI: 10.1016/j.plasmid.2006.11.001

Source DB:  PubMed          Journal:  Plasmid        ISSN: 0147-619X            Impact factor:   3.466


  11 in total

1.  Anti-tumor efficacy of plasmid encoding emm55 in a murine melanoma model.

Authors:  Brittany L Bunch; Krithika N Kodumudi; Ellen Scott; Jennifer Morse; Amy Mackay Weber; Anders E Berglund; Shari Pilon-Thomas; Joseph Markowitz
Journal:  Cancer Immunol Immunother       Date:  2020-06-18       Impact factor: 6.968

2.  Bioengineered bugs, drugs and contentious issues in patenting.

Authors:  Ananda M Chakrabarty
Journal:  Bioeng Bugs       Date:  2010 Jan-Feb

Review 3.  Microbial-based therapy of cancer: current progress and future prospects.

Authors:  Nuno Bernardes; Raquel Seruca; Ananda M Chakrabarty; Arsenio M Fialho
Journal:  Bioeng Bugs       Date:  2009-12-02

4.  Structural studies on Laz, a promiscuous anticancer Neisserial protein.

Authors:  Wataru Hashimoto; Akihito Ochiai; Chang Soo Hong; Kousaku Murata; Ananda M Chakrabarty
Journal:  Bioengineered       Date:  2015-02-25       Impact factor: 3.269

5.  A novel and rapid LC/MS/MS assay for bioanalysis of Azurin p28 in serum and its pharmacokinetics in mice.

Authors:  Greg S Gorman; Lori U Coward; Lea Freeman; Pat E Noker; Craig W Beattie; Lee Jia
Journal:  J Pharm Biomed Anal       Date:  2010-06-30       Impact factor: 3.935

6.  Bacteria under SOS evolve anticancer phenotypes.

Authors:  Shatha F Dallo; Tao Weitao
Journal:  Infect Agent Cancer       Date:  2010-02-05       Impact factor: 2.965

7.  Escherichia coli Nissle 1917 targets and restrains mouse B16 melanoma and 4T1 breast tumors through expression of azurin protein.

Authors:  Yunlei Zhang; Youming Zhang; Liqiu Xia; Xiangli Zhang; Xuezhi Ding; Fu Yan; Feng Wu
Journal:  Appl Environ Microbiol       Date:  2012-08-24       Impact factor: 4.792

Review 8.  Anticancer Actions of Azurin and Its Derived Peptide p28.

Authors:  Fan Huang; Qianhui Shu; Zhaojie Qin; Jianglin Tian; Zhengding Su; Yongqi Huang; Meng Gao
Journal:  Protein J       Date:  2020-04       Impact factor: 2.371

9.  Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 production.

Authors:  Tai-An Chen; Jui-Ling Wang; Shao-Wen Hung; Chiao-Li Chu; Yung-Chih Cheng; Shu-Mei Liang
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

10.  Dose-effect relationship of CpG oligodeoxyribonucleotide 1826 in murine Lewis lung cancer treated with irradiation.

Authors:  Xibing Zhuang; Tiankui Qiao; Sujuan Yuan; Wei Chen; Lin Zha; Li Yan
Journal:  Onco Targets Ther       Date:  2013-05-20       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.